Enterolactone in breast cyst fluid: Correlation with EGF and breast cancer risk

Breast Cancer Research and Treatment

Volumn 79, Issue 1, 2003, Pages 17-23

  Boccardo, Francesco ^a   Lunardi, Gian Luigi ^a   Petti, Anna Rita ^a   Rubagotti, Alessandra ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

Breast cancer risk; Breast cyst fluid; Enterolactone; Epidermal growth factor; Type I cysts; Type II cysts

Indexed keywords

ENTEROLACTONE; EPIDERMAL GROWTH FACTOR;

ADULT; AGED; ARTICLE; BLOOD LEVEL; BREAST CANCER; BREAST CARCINOGENESIS; BREAST CYST; CANCER RISK; COHORT ANALYSIS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION ANALYSIS; CYST FLUID; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PREDICTION; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

4-BUTYROLACTONE; ADULT; AGED; BREAST NEOPLASMS; EPIDERMAL GROWTH FACTOR; EXUDATES AND TRANSUDATES; FEMALE; FIBROCYSTIC BREAST DISEASE; HUMANS; LIGNANS; MIDDLE AGED; ODDS RATIO; PREDICTIVE VALUE OF TESTS; RISK FACTORS; STATISTICS;

EID: 0038703516     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1023356209478     Document Type: Article

References (25)

1. Reinli K, Block G: Phytoestrogen content of foods - a compendium of literature values. Nutr Cancer 26: 123-148, 1996
2. Setchell KDR, Adlercreutz H: Mammalian lignans and phytooestrogens: recent studies on their formation, metabolism and biological role in health and disease. In: Rowland IR (ed) Role of the Gut Flora in Toxicity and Cancer. Academic Press, London, 1998, pp 315-345
3. Lee HP, Gourley L, Duffy SW, Esteve J, Lee J, Day NE: Dietary effects on breast-cancer risk in Singapore. Lancet 337: 1197-1200, 1991
4. Yuan JM, Wang QS, Ross RK, Henderson BE, Yu MC: Diet and breast cancer in Shanghai and Tianjin, China. Br J Cancer 71: 1353-1358, 1995
5. Ingram D, Sanders K, Kolybaba M, Lopez D: Case-control study of phyto-oestrogens and breast cancer. Lancet 350: 990-994, 1997
6. Pietinen P, Stumpf K, Mannisto S, Kataja V, Uusitupa M, Adlercreutz H: Serum enterolactone and risk of breast cancer: a case-control study in eastern Finland. Cancer Epidemiol Biomarkers Prev 10: 339-344, 2001
7. Morton MS, Chan PS, Cheng C, Blacklock N, Matos-Ferreira A, Abranches-Monteiro L, Correia R, Lloyd S, Griffiths K: Lignans and isoflavonoids in plasma and prostatic fluid in men: samples from Portugal, Hong Kong, and the United Kingdom. Prostate 32: 122-128, 1997
8. Franke AA, Custer LJ, Tanaka Y: Isoflavones in human breast milk and other biological fluids. Am J Clin Nutr 68(Suppl 6): 1466-1473, 1998
9. Boccardo F, Marenghi C, Ghione G, Pepe A, Parodi S, Rubagotti A: Intracystic epidermal growth factor level is predictive of breast-cancer risk in women with gross cystic disease of the breast. Int J Cancer 95: 260-265, 2001
10. Boccardo F, Valenti G, Zanardi S, Cerruti G, Fassio T, Bruzzi P, De Franchis V, Barreca A, Del Monte P, Minuto F: Epidermal growth factor in breast cyst fluid: relationship with intracystic cation and androgen conjugate content. Cancer Res 48: 5860-5863, 1988
11. Stumpf K, Pietinen P, Puska P, Adlercreutz H: Changes in serum enterolactone, genistein, and daidzein in a dietary intervention study in Finland. Cancer Epidemiol Biomarkers Prev 9: 1369-1372, 2000
12. Fliess JL: Statistical Methods for Rates and Proportions. Wiley, New York, 1991
13. Siegel S: Non-parametric Statistics. McGraw-Hill Kogakusha, Ltd, London, 1959
14. Zeleniuch-Jacquotte A, Adlercreutz H, Akhmedkhanov A, Toniolo P: Reliability of serum measurements of lignans and isoflavonoid phytoestrogens over a two-year period. Cancer Epidemiol Biomarkers Prev 7: 885-889, 1998
15. Dixon JM, Miller WR, Scott WN, Forrest AP: The morphological basis of human breast cyst populations. Br J Surg 70: 604-606, 1983
16. Dixon JM, McDonald C, Elton RA, Miller WR: Risk of breast cancer in women with palpable breast cysts: a prospective study. Edinburgh Breast Group. Lancet 353: 1742-1745, 1999
17. Boccardo F, Torrisi R, Zanardi S, Valenti G, Pensa F, De Franchis V, Barreca A, Ferraro P, Minuto F: EGF in breast cyst fluid: relationships with intracystic androgens, estradiol and progesterone. Int J Cancer 47: 523-526, 1991
18. Belanger A, Caron S, Labrie F, Naldoni C, Dogliotti L, Angeli A: Levels of eighteen non-conjugated and conjugated steroids in human breast cyst fluid: relationships with cyst type. Eur J Cancer 26: 277-281, 1990
19. Bradlow HL, Rosenfeld RS, Kream J, Fleisher M, O'Connor J, Schwartz MK: Steroid hormone accumulation in human breast cyst fluid. Cancer Res 41: 105-107, 1981
20. Lai LC, Ghatei MA, Takahashi K, Patel KV, Schrey MP, Ghilchik MW, Bloom SR, James VH: Mitogenic peptides in breast cyst fluid: relationship with intracystic electrolyte ratios. Int J Cancer 46: 1014-1016, 1990
21. Zanardi S, Pensa F, Torrisi R, de Franchis V, Barreca A, Minuto F, Boccardo F: Presence and distribution of growth factors in breast cyst fluid. Ann NY Acad Sci 784: 542-549, 1996
22. Ness JC, Sedghinasab M, Moe RE, Tapper D: Identification of multiple proliferative growth factors in breast cyst fluid. Am J Surg 166: 237-243, 1993
23. Welshons WV, Murphy CS, Koch R, Calaf G, Jordan VC: Stimulation of breast cancer cells in vitro by the environmental estrogen enterolactone and the phytoestrogen equol. Breast Cancer Res Treat 10: 169-175, 1987
24. Wang C, Kurzer MS: Phytoestrogen concentration determines effects on DNA synthesis in human breast cancer cells. Nutr Cancer 28(3): 236-247, 1997
25. Wang C, Kurzer MS: Effects of phytoestrogens on DNA synthesis in MCF-7 cells in the presence of estradiol or growth factors. Nutr Cancer 31: 90-100, 1998